Neck Surgery Articles & Analysis
18 news found
(TSX-V: PINK)(OTC: PYNKF) (FSE: 4PC) (“Perimeter” or the “Company”) announced the publication of a peer-reviewed research article in JAMA Otolaryngology—Head and Neck Surgery. The study’s findings validate the further exploration of the use of Perimeter’s wide-field Optical Coherence Tomography (WF-OCT) technology to ...
There are so many dental surgery types available, some patients struggle to understand how and why they need a particular surgery performed. ...
Jeremy Richmon, MD is leading a new clinical trial sponsored by Alume, the Center for Clinical Research Operations' (CCRO) first clinical trial with Head and Neck Surgery. The trial involves using a tracer to help identify nerves intraoperatively. ...
Tissuemed Ltd. was recently able to support the 2nd African Head and Neck Society (AfHNS) Conference. The company’s TissuePatch surgical sealant film is a useful adjunct to ENT and Head and and Neck Surgery, often used to seal tissue surfaces and therefore minimise the need for postoperative drainage. ...
This Phase I-II study relates to the Investigational New Drug (IND) application for the use of ALM-488 in head and neck surgery. ALM-488 was developed by Alume Biosciences Inc. and is an intravenously administered peptide-dye conjugate for fluorescence highlighting of nerves during surgery. ...
Sewall Professor, Stanford University School of Medicine, Department of Otolaryngology – Head & Neck Surgery and Institute for Stem Cell Biology and Regenerative Medicine ISCBRM. ...
“After treating my first two patients with PROPEL Contour post-functional endoscopic sinus surgery in August 2021, I was pleased with the design of the PROPEL Contour sinus implant for patients with variable frontal sinus openings that are suffering from chronic rhinosinusitis,” said Prof. ...
The American Academy of Otolaryngology–Head and Neck Surgery (AAO-HNS), in partnership with Intersect ENT, Inc., launched a public education campaign that provides clinically-developed information by experts in the field aimed at helping people better understand their nasal and sinus symptoms. ...
Sisson Professor and Chair, Department of Otolaryngology, Head and Neck Surgery, Northwestern University Feinberg School of Medicine, will moderate a discussion with two ENT physicians who are renowned experts in CRS: Dr. Amber Luong, MD, PhD, FACS, Professor and Vice Chair for Research in Otorhinolaryngology, Head & Neck ...
VirtuEye photo registration is an exclusive and novel, touchless technology that allows for easy 3D facial registration, pinpoint accuracy and improved workflow efficiency for balloon sinus dilation (BSD) procedures and other ENT related skull-based surgeries. With the addition of the Cube and VenSure technologies to the already clinically proven portfolio of localized drug ...
PROPEL Contour is specifically designed to maintain patency and reduce inflammation, and conform to the sinus ostia (openings) by focusing mechanical support and steroid delivery where it is needed to optimize sinus surgery outcomes. It is the third localized drug delivery implant, completing the PROPEL family of drug-eluting, bioabsorable implants now available to ENT ...
ALM-488 is an investigational fluorescently labelled nerve targeting pharmaceutical being developed as an adjunct for the visualization of nerves at risk for injury during head and neck surgery. The Fast Track designation was approved by the FDA Division of Medical Imaging and Radiation Medicine (DMIRM), which is responsible for drug products used in the ...
Chad Zender, Department of Otolaryngology Head and Neck Surgery, University Hospitals Cleveland Medical Center. Yao is also a professor in the radiology department of the Case Western Reserve School of Medicine, and Zender is an associate professor at the Case Western Reserve School of Dental Medicine and in the department of otolaryngology at the University of ...
Based on these results, I believe LYR-210 could represent a viable alternative to invasive nasal surgery for CRS patients, with as few as two ENT office visits a ...
The Phase II SBIR grant is a follow-on 2–year award that will support testing of Alume's fluorescent nerve targeting agent in an ongoing Phase 1/2 clinical trial in patients undergoing Head and Neck Surgery. "Alume's technology was developed out of the unmet need to improve intraoperative identification of nerves to avoid inadvertent injury," said Quyen ...
Head and neck cancer surgery presents a number of unique challenges, not only for the surgeon but for the radiation oncologist who will subsequently treat those patients. ...
(Sofregen), an early stage commercial biotechnology company developing products for medical aesthetics and reconstructive surgery, announced today that Silk Voice has been cleared by the U.S. ...
The American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) Annual Meeting & OTO Expo will take place in Chicago, Illinois on September 10-13, 2017. ...